|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/337 | |
| A61K 31/55 | |||
| A61K 35/00 |
| (11) | Number of the document | 2827855 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13714455.6 |
| Date of filing the European patent application | 2013-03-19 | |
| (97) | Date of publication of the European application | 2015-01-28 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/032962 |
| Date | 2013-03-19 |
| (87) | Number | WO 2013/142491 |
| Date | 2013-09-26 |
| (30) | Number | Date | Country code |
| 201261613258 P | 2012-03-20 | US |
| (72) |
CHAKRAVARTY, Arijit, US
ECSEDY, Jeffrey, A., US
KLEINFIELD, Robert, W., US
LE, Kha, N., US
SHYU, Wen, Chyi, US
VENKATAKRISHNAN, Karthik, US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (54) | COMBINATION OF ALISERTIB AND PACLITAXEL FOR THE TREATMENT OF CANCER |
| COMBINATION OF ALISERTIB AND PACLITAXEL FOR THE TREATMENT OF CANCER |